ESC Premium Access

Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation

Congress Presentation

About the speaker

Associate Professor David Conen

Population Health Research Institute, Hamilton (Canada)
5 presentations
1 follower

5 more presentations in this session

Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?

Speaker: Professor R. Providencia (London, GB)

Thumbnail

Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure:the PFO-AF study

Speaker: Doctor M. Badoz (Besancon, FR)

Thumbnail

A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis

Speaker: Doctor T. Stegmann (Leipzig, DE)

Thumbnail

Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III

Speaker: Doctor B. Corica (Modena, IT)

Thumbnail

Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry

Speaker: Professor J. Brachmann (Coburg, DE)

Thumbnail

Access the full session

Registries, observational, and other studies on atrial fibrillation

Speakers: Associate Professor D. Conen, Professor R. Providencia, Doctor M. Badoz, Doctor T. Stegmann, Doctor B. Corica...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations